KalVista Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KALV and other ETFs, options, and stocks.About KALV
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa.
KALV Key Statistics
Stock Snapshot
As of today, KalVista Pharmaceuticals(KALV) shares are valued at $26.71. The company's market cap stands at 1.37B, with a P/E ratio of -6.68.
As of 2026-05-12, KalVista Pharmaceuticals(KALV) stock has fluctuated between $26.69 and $26.73. The current price stands at $26.71, placing the stock +0.1% above today's low and -0.1% off the high.
KalVista Pharmaceuticals(KALV) shares are trading with a volume of 1.23M, against a daily average of 11.26M.
During the past year, KalVista Pharmaceuticals(KALV) stock moved between $9.83 at its lowest and $26.85 at its peak.
During the past year, KalVista Pharmaceuticals(KALV) stock moved between $9.83 at its lowest and $26.85 at its peak.
Analyst ratings
86%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.